Androgenetic Alopecia study: PP405 vs Vehicle Topical Gel
Official title Phase 2/3 Efficacy and Safety of PP405 in Adult Males
ClinicalTrials.gov ID: NCT07819435
What this study is testing
What is PP405 0.05% Topical Gel?
PP405 0.05% Topical Gel is an investigational topical gel being studied as a potential treatment for androgenetic alopecia.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether PP405 can improve hair growth and is safe for long‑term use in men with androgenetic alopecia.
- Who it's for
- You may be able to join if you are an adult man with male pattern hair loss.
- What's involved
- You will receive PP405 as directed and may have a few check‑in visits to track your hair and any side effects.
- Time commitment
- The study lasts several months and includes regular visits to monitor your progress.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, men only
You may be able to join if
- Males (assigned at birth) aged 18 to 55 years, inclusive at time of consent.
- Able and willing to provide written informed consent
- Must have been experiencing Androgenetic Alopecia (AGA) for at least 6 months prior to screening.
- Have a modified Norwood-Hamilton score of Type IV or Type V
- Agree to comply with protocol procedures
You likely can't join if
- Concomitant diagnosis of non-AGA forms of alopecia.
- Use of other hair loss treatments within periods specified in protocol.
- Use of excluded medications and procedures as specified in protocol.
- Diagnosis of other medical conditions as specified in protocol.
- Any disease or medical condition that, in the opinion of the Investigator, would prevent the subject from participating in the study or might...
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Fort Smith, Arkansas, United States
- Hot Springs, Arkansas, United States
- Manhattan Beach, California, United States
- Thousand Oaks, California, United States
- Boca Raton, Florida, United States
- Coral Gables, Florida, United States
- Tampa, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
- Indianapolis, Indiana, United States
- Plainfield, Indiana, United States
- Baton Rouge, Louisiana, United States
- New Orleans, Louisiana, United States
- Clinton Township, Michigan, United States
- Troy, Michigan, United States
- New Brighton, Minnesota, United States
- Wildwood, Missouri, United States
- New York, New York, United States
- The Bronx, New York, United States
+ 12 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Fort Smith, Arkansas, United States; Hot Springs, Arkansas, United States; Manhattan Beach, California, United States; Thousand Oaks, California, United States; Boca Raton, Florida, United States and 26 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.